Drug Shortage Report for MYLAN-IRBESARTAN
| Report ID | 9203 |
| Drug Identification Number | 02347318 |
| Brand name | MYLAN-IRBESARTAN |
| Common or Proper name | IRBESARTAN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-07-03 |
| Actual start date | 2018-07-03 |
| Estimated end date | 2018-08-10 |
| Actual end date | 2018-08-10 |
| Shortage status | Resolved |
| Updated date | 2018-08-11 |
| Company comments | Discontinued in report 44867 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2018-08-11 | English | Compare |
| v16 | 2018-08-10 | French | Compare |
| v15 | 2018-08-10 | English | Compare |
| v14 | 2018-07-31 | French | Compare |
| v13 | 2018-07-31 | English | Compare |
| v12 | 2018-07-05 | French | Compare |
| v11 | 2018-07-05 | English | Compare |
| v10 | 2018-07-04 | English | Compare |
| v9 | 2018-07-03 | French | Compare |
| v8 | 2018-07-03 | English | Compare |
| v7 | 2018-04-04 | French | Compare |
| v6 | 2018-04-04 | English | Compare |
| v5 | 2017-11-10 | French | Compare |
| v4 | 2017-11-10 | English | Compare |
| v3 | 2017-11-10 | English | Compare |
| v2 | 2017-05-05 | French | Compare |
| v1 | 2017-05-05 | English | Compare |
Showing 1 to 17 of 17